Selected research
Industry Research
Virus-like Particles (VLPs) Delivery System Industry Research Report 2026
Market perspective
The global Virus-like Particles (VLPs) Delivery System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Virus-like Particles (VLPs) Delivery System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Virus-like Particles (VLPs) Delivery System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Virus-like Particles (VLPs) Delivery System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Virus-like Particles (VLPs) Delivery System include WuXi Biologics, Creative Biolabs, Creative Biogene, Creative Biostructure, Cusabio Technology LLC, Creative Diagnostics and ARTES Biotechnology GmbH, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Virus-like Particles (VLPs) Delivery System market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Virus-like Particles (VLPs) Delivery System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Virus-like Particles (VLPs) Delivery System Market by Company
WuXi Biologics
Creative Biolabs
Creative Biogene
Creative Biostructure
Cusabio Technology LLC
Creative Diagnostics
ARTES Biotechnology GmbH
Virus-like Particles (VLPs) Delivery System Segment by Type
Insect Cell System
Mammalian Cell System
Plant System
Yeast System
E. coli System
Virus-like Particles (VLPs) Delivery System Segment by Application
DNA
RNA
Peptide
Protein
Other
Virus-like Particles (VLPs) Delivery System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Virus-like Particles (VLPs) Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Virus-like Particles (VLPs) Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Virus-like Particles (VLPs) Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Virus-like Particles (VLPs) Delivery System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Insect Cell System
- Mammalian Cell System
- Plant System
- Yeast System
- E. coli System
Applications
- DNA
- RNA
- Peptide
- Protein
- Other
Companies covered
- WuXi Biologics
- Creative Biolabs
- Creative Biogene
- Creative Biostructure
- Cusabio Technology LLC
- Creative Diagnostics
- ARTES Biotechnology GmbH
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Virus-like Particles (VLPs) Delivery System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Insect Cell System
- 2.2.3 Mammalian Cell System
- 2.2.4 Plant System
- 2.2.5 Yeast System
- 2.2.6 E. coli System
- 2.3 Virus-like Particles (VLPs) Delivery System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 DNA
- 2.3.3 RNA
- 2.3.4 Peptide
- 2.3.5 Protein
- 2.3.6 Other
- 2.4 Assumptions and Limitations
3 Virus-like Particles (VLPs) Delivery System Breakdown Data by Type
- 3.1 Global Virus-like Particles (VLPs) Delivery System Historic Market Size by Type (2021-2026)
- 3.2 Global Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Type (2027-2032)
4 Virus-like Particles (VLPs) Delivery System Breakdown Data by Application
- 4.1 Global Virus-like Particles (VLPs) Delivery System Historic Market Size by Application (2021-2026)
- 4.2 Global Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Virus-like Particles (VLPs) Delivery System Market Perspective (2021-2032)
- 5.2 Global Virus-like Particles (VLPs) Delivery System Growth Trends by Region
- 5.2.1 Global Virus-like Particles (VLPs) Delivery System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Virus-like Particles (VLPs) Delivery System Historic Market Size by Region (2021-2026)
- 5.2.3 Virus-like Particles (VLPs) Delivery System Forecasted Market Size by Region (2027-2032)
- 5.3 Virus-like Particles (VLPs) Delivery System Market Dynamics
- 5.3.1 Virus-like Particles (VLPs) Delivery System Industry Trends
- 5.3.2 Virus-like Particles (VLPs) Delivery System Market Drivers
- 5.3.3 Virus-like Particles (VLPs) Delivery System Market Challenges
- 5.3.4 Virus-like Particles (VLPs) Delivery System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Virus-like Particles (VLPs) Delivery System Players by Revenue
- 6.1.1 Global Top Virus-like Particles (VLPs) Delivery System Players by Revenue (2021-2026)
- 6.1.2 Global Virus-like Particles (VLPs) Delivery System Revenue Market Share by Players (2021-2026)
- 6.2 Global Virus-like Particles (VLPs) Delivery System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Virus-like Particles (VLPs) Delivery System Head Office and Area Served
- 6.4 Global Virus-like Particles (VLPs) Delivery System Players, Product Type & Application
- 6.5 Global Virus-like Particles (VLPs) Delivery System Manufacturers Established Date
- 6.6 Global Virus-like Particles (VLPs) Delivery System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Virus-like Particles (VLPs) Delivery System Market Size (2021-2032)
- 7.2 North America Virus-like Particles (VLPs) Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Virus-like Particles (VLPs) Delivery System Market Size by Country (2021-2026)
- 7.4 North America Virus-like Particles (VLPs) Delivery System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Virus-like Particles (VLPs) Delivery System Market Size (2021-2032)
- 8.2 Europe Virus-like Particles (VLPs) Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Virus-like Particles (VLPs) Delivery System Market Size by Country (2021-2026)
- 8.4 Europe Virus-like Particles (VLPs) Delivery System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Virus-like Particles (VLPs) Delivery System Market Size (2021-2032)
- 9.2 Asia-Pacific Virus-like Particles (VLPs) Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Virus-like Particles (VLPs) Delivery System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Virus-like Particles (VLPs) Delivery System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Virus-like Particles (VLPs) Delivery System Market Size (2021-2032)
- 10.2 South America Virus-like Particles (VLPs) Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Virus-like Particles (VLPs) Delivery System Market Size by Country (2021-2026)
- 10.4 South America Virus-like Particles (VLPs) Delivery System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Virus-like Particles (VLPs) Delivery System Market Size (2021-2032)
- 11.2 Middle East & Africa Virus-like Particles (VLPs) Delivery System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Virus-like Particles (VLPs) Delivery System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Virus-like Particles (VLPs) Delivery System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 WuXi Biologics
- 12.1.1 WuXi Biologics Company Information
- 12.1.2 WuXi Biologics Business Overview
- 12.1.3 WuXi Biologics Revenue in Virus-like Particles (VLPs) Delivery System Business (2021-2026)
- 12.1.4 WuXi Biologics Virus-like Particles (VLPs) Delivery System Product Portfolio
- 12.1.5 WuXi Biologics Recent Developments
- 12.2 Creative Biolabs
- 12.2.1 Creative Biolabs Company Information
- 12.2.2 Creative Biolabs Business Overview
- 12.2.3 Creative Biolabs Revenue in Virus-like Particles (VLPs) Delivery System Business (2021-2026)
- 12.2.4 Creative Biolabs Virus-like Particles (VLPs) Delivery System Product Portfolio
- 12.2.5 Creative Biolabs Recent Developments
- 12.3 Creative Biogene
- 12.3.1 Creative Biogene Company Information
- 12.3.2 Creative Biogene Business Overview
- 12.3.3 Creative Biogene Revenue in Virus-like Particles (VLPs) Delivery System Business (2021-2026)
- 12.3.4 Creative Biogene Virus-like Particles (VLPs) Delivery System Product Portfolio
- 12.3.5 Creative Biogene Recent Developments
- 12.4 Creative Biostructure
- 12.4.1 Creative Biostructure Company Information
- 12.4.2 Creative Biostructure Business Overview
- 12.4.3 Creative Biostructure Revenue in Virus-like Particles (VLPs) Delivery System Business (2021-2026)
- 12.4.4 Creative Biostructure Virus-like Particles (VLPs) Delivery System Product Portfolio
- 12.4.5 Creative Biostructure Recent Developments
- 12.5 Cusabio Technology LLC
- 12.5.1 Cusabio Technology LLC Company Information
- 12.5.2 Cusabio Technology LLC Business Overview
- 12.5.3 Cusabio Technology LLC Revenue in Virus-like Particles (VLPs) Delivery System Business (2021-2026)
- 12.5.4 Cusabio Technology LLC Virus-like Particles (VLPs) Delivery System Product Portfolio
- 12.5.5 Cusabio Technology LLC Recent Developments
- 12.6 Creative Diagnostics
- 12.6.1 Creative Diagnostics Company Information
- 12.6.2 Creative Diagnostics Business Overview
- 12.6.3 Creative Diagnostics Revenue in Virus-like Particles (VLPs) Delivery System Business (2021-2026)
- 12.6.4 Creative Diagnostics Virus-like Particles (VLPs) Delivery System Product Portfolio
- 12.6.5 Creative Diagnostics Recent Developments
- 12.7 ARTES Biotechnology GmbH
- 12.7.1 ARTES Biotechnology GmbH Company Information
- 12.7.2 ARTES Biotechnology GmbH Business Overview
- 12.7.3 ARTES Biotechnology GmbH Revenue in Virus-like Particles (VLPs) Delivery System Business (2021-2026)
- 12.7.4 ARTES Biotechnology GmbH Virus-like Particles (VLPs) Delivery System Product Portfolio
- 12.7.5 ARTES Biotechnology GmbH Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst